Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Cardiovascular
Prevalence
5.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)?
There are 2 clinical trials targeting Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) tracked by BioSniper.
What is the prevalence of Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)?
The estimated prevalence of Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) is approximately 5.0 per 100,000 population.
Deep-dive into Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis